Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
US11548893B2 · kind B2 · utility
0Cited by
40References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2018 |
| Grant date | Jan 10, 2023 |
| Priority date | — |
| Expiry date | Jul 11, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds of the invention as shown by general structure I, as shown below, are effective in treating filovirus infections. These compounds are effective in treating filovirii infections including Ebolavirus and Marburg virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.